Celsion Corp (CLSN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael H. Tardugno
Employees:
29
997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ 08648
(609) 896-9100

Celsion Corp. is an oncology drug development company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA- based therapies. Its products include Celsion, ThermoDox, EGEN, TheraPlas and TheraSilence. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Data derived from most recent annual or quarterly report
Market Cap 36.181 Million Shares Outstanding86.558 Million Avg 30-day Volume 739.228 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.15
Price to Revenue238.8994 Debt to Equity0.0926 EBITDA-21.752 Million
Price to Book Value2.1734 Operating Margin-3820.7602 Enterprise Value71.779 Million
Current Ratio8.407 EPS Growth0.263 Quick Ratio7.886
1 Yr BETA 0.9778 52-week High/Low 3.48 / 0.35 Profit Margin-4423.1372
Operating Cash Flow Growth21.9194 Altman Z-Score-2.3383 Free Cash Flow to Firm -10.494 Million

Are you looking for this stock instead?

View SEC Filings from CLSN instead.

View recent insider trading info

Funds Holding CLSN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLSN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KARDARAS CONSTANTINE JOHN CHIEF ACCOUNTING OFFICER

  • Officer
0 2021-12-14 2

FRITZ FREDERICK J.

  • Director
71,491 2021-10-07 2

PELLIZZARI CHRISTINE A

  • Director
0 2021-06-09 2

LINDBORG STACY

  • Director
40,000 2021-06-04 2

BRAUN DONALD P

  • Director
5,357 2021-05-17 2

CHURCH JEFFREY WAYNE CFO

  • Officer
714,951 2021-03-19 1

TARDUGNO MICHAEL H CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
1,996,071 2021-03-19 1

CHOW POK YU AUGUSTINE

  • Director
183,689 2021-03-19 1

TUMMINELLO TIMOTHY J CONTROLLER

  • Officer
214,557 2021-03-19 1

HOOPER ROBERT W

  • Director
179,737 2021-03-19 1

VOSS ANDREAS

  • Director
151,357 2021-03-19 1

MARTINEZ ALBERTO R JR

  • Director
0 2020-06-15 0

BORYS NICHOLAS CMO

  • Officer
0 2019-02-19 0

ANWER KHURSHEED CHIEF SCIENTIFIC OFFICER

  • Officer
0 2018-05-15 0

EGWU, INC. FKA EGEN, INC.

  • 10% Owner
2,421,867 2015-12-03 0

LINK MAX

  • Director
0 2014-06-20 0

WEAVER GREGORY L CFO

  • Officer
28,636 2011-12-06 0

PACE GARY W

  • Director
0 2010-02-19 0

MORAN SEAN F. CHIEF FINANCIAL OFFICER

  • Officer
35,000 2009-03-17 0

SUSIE PAUL B. CHIEF ACCOUNTING OFFICER

  • Officer
0 2008-02-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KARDARAS CONSTANTINE JOHN - Officer CHIEF ACCOUNTING OFFICER

2021-12-16 16:42:47 -0500 2021-12-14 A 10,000 a 10,000 direct -0.627 -7.3668 0.4702 4 -7.3668 6

KARDARAS CONSTANTINE JOHN - Officer CHIEF ACCOUNTING OFFICER

2021-12-16 16:42:47 -0500 2021-12-14 A 35,000 $0.63 a 35,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CELSION CORP CLSN 2022-01-28 15:15:03 UTC -2.3012 2.3712 2100000
CELSION CORP CLSN 2022-01-28 14:45:03 UTC -2.3012 2.3712 2100000
CELSION CORP CLSN 2022-01-28 14:15:03 UTC -2.3012 2.3712 2100000
CELSION CORP CLSN 2022-01-28 13:45:03 UTC -2.3012 2.3712 2100000
CELSION CORP CLSN 2022-01-28 13:15:03 UTC -2.3012 2.3712 2100000
CELSION CORP CLSN 2022-01-28 12:45:03 UTC -2.3012 2.3712 2100000
CELSION CORP CLSN 2022-01-27 22:15:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 21:45:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 21:15:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 20:45:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 20:15:04 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 19:45:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 19:15:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 18:45:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 18:15:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 17:45:03 UTC -2.3012 2.3712 2500000
CELSION CORP CLSN 2022-01-27 17:15:03 UTC -2.3012 2.3712 2600000
CELSION CORP CLSN 2022-01-27 16:45:03 UTC -2.3012 2.3712 2600000
CELSION CORP CLSN 2022-01-27 16:15:03 UTC -2.3012 2.3712 2600000
CELSION CORP CLSN 2022-01-27 15:45:02 UTC -2.3012 2.3712 2300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments